Möglichkeiten und Grenzen der Kapillarmikroskopie in der Kinderrheumatologie

Zusammenfassung

Die Kapillarmikroskopie erfasst im Rahmen entzündlich rheumatischer Erkrankungen strukturelle Störungen der Mikrozirkulation. Das Verfahren ist aktuell vor allem für die Diagnostik und Verlaufsbeobachtung erwachsener Patienten mit Raynaud-Syndrom oder systemischer Sklerose (Sklerodermie) etabliert, steht jedoch als nicht invasives Verfahren grundsätzlich auch für die Untersuchung von Kindern und Jugendlichen zur Verfügung. Dieser Übersichtsartikel stellt Befunde bei gesunden Kindern und Jugendlichen sowie charakteristische Befunde bei entzündlichen Systemerkrankungen des Kindesund Jugendalters wie der juvenilen idiopathischen Arthritis, der juvenilen systemischen Sklerose und der juvenilen Dermatomyositis sowie dem Raynaud-Phänomen dar, und fasst abschließend die aktuellen Möglichkeiten und Grenzen der Kapillarmikroskopie als bildgebende Methode im klinischen Alltag pädiatrischer Rheumatologien zusammen.

Summary

Nailfold capillarscopy is a valid method to display and evaluate structural dysfunction of the microcirculation in systemic inflammatory diseases. It is widely established as a diagnostic procedure at disease onset and for follow-up of adult patients with Raynaud’s phenomenon or systemic sclerosis, but may also be available for non-invasive examination of children and adolescents with respective diseases. The review will give an overview of characteristic findings in healthy children and adolescents as well as in children with juvenile idiopathic arthritis, juvenile systemic sclerosis, juvenile dermatomyositis and Raynaud’s phenomenon. Possibilities and limitations of nailfold capillaroscopy for daily care in pediatric rheumatology will be presented in conclusion.

Schlüsselwörter

Kapillarmikroskopie - rheumatische Erkrankungen - Kinderrheumatologie

Keywords

Nailfold capillaroscopy - rheumatic diseases - pediatric rheumatology

• Literatur

• 1 Maricq HR, Spencer-Green G, LeRoy EC. Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud’s syndrome and dermatomyositis. The American journal of medicine 1976; 61 (06) 862-70.
• 2 Maricq HR. et al. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis and rheumatism 1980; 23 (02) 183-9.
• 3 Houtman PM. et al. Decreased nailfold capillary density in Raynaud’s phenomenon: a reflection of immunologically mediated local and systemic vascular disease?. Annals of the rheumatic diseases 1985; 44 (09) 603-9.
• 4 Sander O. et al. [Capillaroscopy. Procedure and nomenclature]. Kapillarmikroskopie. Durchführung und Nomenklatur. Zeitschrift fur Rheumatologie 2010; 69 (03) 253-62.
• 5 Callander CL. Photomicrographic studies of morphology of surface, capillaries in health and disease I. The anatomy of normal surface capilaries and on a photographic method of their observation and recording. J Amer Med Assoc 1925; 84: 352-6.
• 6 Jayanetti S. et al. Thermography and nailfold capillaroscopy as noninvasive measures of circulation in children with Raynaud’s phenomenon. The Journal of rheumatology 1998; 25 (05) 997-9.
• 7 Cony MI. et al. [Periungual capillaroscopy patterns in normal children]. Etude des aspects capillaroscopiques peri-ungueaux chez l’enfant normal. Archives francaises de pediatrie 1992; 49 (03) 171-4.
• 8 Martino F. et al. [Nailfold capillaroscopy in normal children between 0 and 16 years of age]. La capillaroscopia periungueale in soggetti normali di eta compresa tra 0 e 16 anni. Minerva pediatrica 1997; 49 (05) 197-201.
• 9 Terreri MT. et al. Nail fold capillaroscopy: normal findings in children and adolescents. Seminars in arthritis and rheumatism 1999; 29 (01) 36-42.
• 10 Herrick AL, Moore T, Hollis S, Jayson MI. The influence of age on nailfold capillary dimensions in childhood. The Journal of rheumatology 2000; 27 (03) 797-800.
• 11 Dolezalova P, Young SP, Bacon PA, Southwood TR. Nailfold capillary microscopy in healthy children and in childhood rheumatic diseases: a prospective single blind observational study. Annals of the rheumatic diseases 2003; 62 (05) 444-9.
• 12 Ingegnoli F, Zeni S, Gerloni V, Fantini F. Capillaroscopic observations in childhood rheumatic diseases and healthy controls. Clinical and experimental rheumatology 2005; 23 (06) 905-11.
• 13 Gorska A. et al. Impairment of microcirculation in juvenile idiopathic arthritis – studies by nailfold videocapillaroscopy and correlation with serum levels of sICAM and VEGF. Folia histochemica et cytobiologica/Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2008; 46 (04) 443-7.
• 14 Wildt M. et al. Capillary density in patients with systemic sclerosis, as determined by microscopy counts and compared with computer-based analysis. Clinical and experimental rheumatology 1999; 17 (02) 219-22.
• 15 John H, Kitas G. Inflammatory arthritis as a novel risk factor for cardiovascular disease. European journal of internal medicine. 2012 Epub 2012/07/31.
• 16 Lambova SN, Muller-Ladner U. Capillaroscopic pattern in inflammatory arthritis. Microvascular research 2012; 83 (03) 318-22.
• 17 Spencer-Green G, Crowe WE, Levinson JE. Nailfold capillary abnormalities and clinical outcome in childhood dermatomyositis. Arthritis and rheumatism 1982; 25 (08) 954-8.
• 18 Lambova SN, Muller-Ladner U. The specificity of capillaroscopic pattern in connective autoimmune diseases. A comparison with microvascular changes in diseases of social importance: arterial hypertension and diabetes mellitus. Modern rheumatology/the Japan Rheumatism Association 2009; 19 (06) 600-5.
• 19 Russo RA, Katsicas MM. Clinical characteristics of children with Juvenile Systemic Sclerosis: followup of 23 patients in a single tertiary center. Pediatric rheumatology online journal 2007; 5: 6.
• 20 Ganczarczyk ML, Lee P, Armstrong SK. Nailfold capillary microscopy in polymyositis and dermatomyositis. Arthritis and rheumatism 1988; 31 (01) 116-9.
• 21 Bergman R. et al. The handheld dermatoscope as a nail-fold capillaroscopic instrument. Archives of dermatology 2003; 139 (08) 1027-30.
• 22 Nagy Z, Czirjak L. Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud’s disease. Journal of the European Academy of Dermatology and Venereology: JEADV 2004; 18 (01) 62-8.
• 23 Scheja A, Elborgh R, Wildt M. Decreased capillary density in juvenile dermatomyositis and in mixed connective tissue disease. The Journal of rheumatology 1999; 26 (06) 1377-81.
• 24 Schmeling H. et al. Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis. Rheumatology (Oxford) 2011; 50 (05) 885-93.
• 25 Ostrowski RA. et al. Association of normal nailfold end row loop numbers with a shorter duration of untreated disease in children with juvenile dermatomyositis. Arthritis and rheumatism 2010; 62 (05) 1533-8.
• 26 Christen-Zaech S. et al. Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis. Arthritis and rheumatism 2008; 58 (02) 571-6.
• 27 Stringer E, Singh-Grewal D, Feldman BM. Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features. Arthritis and rheumatism 2008; 58 (11) 3585-92.
• 28 de Holanda Mafaldo Diogenes A. et al. Capillaroscopy is a dynamic process in mixed connective tissue disease. Lupus 2007; 16 (04) 254-8.
• 29 Lefford F, Edwards JC. Nailfold capillary microscopy in connective tissue disease: a quantitative morphological analysis. Annals of the rheumatic diseases 1986; 45 (09) 741-9.
• 30 Harper FE, Maricq HR, Turner RE. et al. A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report. The American journal of medicine 1982; 72 (06) 883-8.
• 31 Houtman PM. et al. Diagnostic significance of nailfold capillary patterns in patients with Raynaud’s phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease. The Journal of rheumatology 1986; 13 (03) 556-63.
• 32 Zufferey P. et al. Prognostic significance of nailfold capillary microscopy in patients with Raynaud’s phenomenon and scleroderma-pattern abnormalities. A six-year follow-up study. Clinical rheumatology 1992; 11 (04) 536-41.
• 33 Koenig M. et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud’s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis and rheumatism 2008; 58 (12) 3902-3912.
• 34 Meli M. et al. Predictive value of nailfold capillaroscopy in patients with Raynaud’s phenomenon. Clinical rheumatology 2006; 25 (02) 153-8.
• 35 Vayssairat M, Priollet P, Goldberg J, Housset E. Nailfold capillary microscopy as a diagnostic tool and in followup examination. Arthritis and rheumatism 1982; 25 (05) 597-8.
• 36 Nigrovic PA, Fuhlbrigge RC, Sundel RP. Raynaud’s phenomenon in children: a retrospective review of 123 patients. Pediatrics 2003; 111 (04) (Suppl. 01) 715-21.
• 37 Pavlov-Dolijanovic S. et al. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients. Pediatric dermatology 2006; 23 (05) 437-42.